Sunday |
4:00 pm - 8:00 pm | Arrival and Check-in |
6:00 pm | Dinner |
7:30 pm - 7:40 pm | Welcome / Introductory Comments by GRC Site Staff |
7:40 pm - 9:30 pm | Keynote Session: Transglutaminases: Multifaceted Enzymes with Multiple Roles in Disease Processes |
| Discussion Leader: Timothy Johnson (UCB, United Kingdom) |
7:40 pm - 7:50 pm | Opening Remarks |
7:50 pm - 8:15 pm | Mauro Piacentini (University of Rome Tor Vergata, Italy) "The Many Faces of Transglutaminases in Disease Processes" |
8:15 pm - 8:20 pm | Discussion |
8:20 pm - 8:45 pm | Kapil Mehta (University of Texas, USA) "Potential Therapeutic Approaches to Manipulating Transglutaminases in Disease Processes" |
8:45 pm - 8:55 pm | Discussion |
8:55 pm - 9:20 pm | Benjamin Drukarch (VU University Medical Center, The Netherlands) "PET Imaging and Its Possible Application in Assessing TG2 Activity" |
9:20 pm - 9:30 pm | Discussion |
Monday |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Modulators, Structures and Substrates of Transglutaminases |
| Discussion Leader: Jeffrey Keillor (University of Ottawa, Canada) |
9:00 am - 9:20 am | Introduction by Discussion Leader |
9:20 am - 9:45 am | Christopher Clouthier (University of Ottawa, Canada) "A Parallel Assessment of TG Conformation and Activity by CE Mass Spec Ion Mobility" |
9:45 am - 9:55 am | Discussion |
9:55 am - 10:20 am | Laszlo Fesus (University of Debrecen, Hungary) "Comparative and Population Genomics Data Reveal Strong Evolutionary Pressure on Structure and Functions of Transglutaminase 2" |
10:20 am - 10:30 am | Discussion |
10:30 am - 11:00 am | Coffee Break |
11:00 am - 11:15 am | Brad Palanski (Stanford University, USA) "Activation of Extracellular TG2" |
11:15 am - 11:20 am | Discussion |
11:20 am - 11:45 am | Muriel Maurer (University of Louisville, USA) "Mass Spectrometry and NMR Approaches for Measuring the Specificity of FXIII Towards Its Substrates" |
11:45 am - 11:55 am | Discussion |
11:55 am - 12:20 pm | Candace Kerr (University of Maryland, USA) "The Inhibition of Transglutaminase Activity in Cancer Stem Cells: Relationship to Conformational Changes and GTP Binding" |
12:20 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:30 pm | Free Time |
4:30 pm - 6:00 pm | Poster Session |
6:00 pm - 8:00 pm | The Function of Transglutaminases in Cardiovascular Disease |
| Discussion Leader: Dan Berkowitz (Johns Hopkins University, USA) |
6:00 pm - 6:20 pm | Introduction by Discussion Leader |
6:20 pm - 6:45 pm | Kelly Beazley (University of Maryland, USA) "New Approaches to Arterial Calcification Through TG2 and Beta-Catenin" |
6:45 pm - 6:55 pm | Discussion |
6:55 pm - 7:15 pm | Erik Bakker (Academic Medical Center, The Netherlands) "TG2 and Vascular Mechanotransduction" |
7:15 pm - 7:25 pm | Discussion |
7:25 pm - 7:50 pm | Lakshmi Santhanam (Johns Hopkins School of Medicine, USA) "TG2:
Separating the Cross Linking-Dependent and Independent Activities in Vascular Disease" |
7:50 pm - 8:00 pm | Discussion |
8:00 pm | Dinner |
Tuesday |
7:30 am - 8:30 am | Breakfast |
8:30 am | Group Photo |
9:00 am - 12:30 pm | Transglutaminases in Tissue Remodeling, Fibrosis and Scarring |
| Discussion Leader: Patricia Sime (University of Rochester Medical Center, USA) |
9:00 am - 9:20 am | Introduction by Discussion Leader |
9:20 am - 9:45 am | Martin Griffin (Aston University, United Kingdom) "A New Strategic Approach to the Treatment of Cardiac Fibrosis (CF) Based on Small-Molecule Inhibitors of TG2" |
9:45 am - 9:55 am | Discussion |
9:55 am - 10:20 am | Elisabetta Verderio (Nottingham Trent University, United Kingdom) "Is Targeting the Transglutaminase-2-Syndecan 4 Interaction a Viable Anti-Fibrotic Strategy?" |
10:20 am - 10:30 am | Discussion |
10:30 am - 11:00 am | Coffee Break |
11:00 am - 11:25 am | Krishna Penumatsa (Tufts Medical Center, USA) "TG2 and Pulmonary Hypertension" |
11:25 am - 11:35 am | Discussion |
11:35 am - 11:55 am | Timothy Johnson (UCB, United Kingdom) "Application of TG2 Inhibitory Antibodies in Treating Kidney Fibrosis: A Translational Perspective" |
11:55 am - 12:00 pm | Discussion |
12:00 pm - 12:10 pm | Selected from Poster Abstracts: Nicole McNeil (University of Ottawa, Canada) "Novel Irreversible Inhibitors of Human Tissue Transglutaminase" |
12:10 pm - 12:15 pm | Discussion |
12:15 pm - 12:25 pm | Selected from Poster Abstracts: Thomas Thatcher (University of Rochester, USA) "Contrasting Pro- and Anti-Fibrotic Roles for Tissue Transglutaminase (TG2) in Lung Fibroblasts and Epithelial Cells" |
12:25 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:30 pm | Free Time |
4:30 pm - 6:00 pm | Poster Session |
6:00 pm - 8:00 pm | Do Transglutaminases Play a Role in Immunology and Rheumatology? |
| Discussion Leader: Riccardo Ientile (University of Messina, Italy) |
6:00 pm - 6:20 pm | Introduction by Discussion Leader |
6:20 pm - 6:45 pm | Zsuzsa Szondy (University of Debrecen, Hungary) "Loss of Transglutaminase 2 Sensitizes for the Development of Various Chronic Inflammatory Diseases" |
6:45 pm - 6:55 pm | Discussion |
6:55 pm - 7:15 pm | Daniela Caccamo (University of Messina, Italy) "Different Transglutaminase Isoforms in Cell Response to Inflammatory Stimuli" |
7:15 pm - 7:25 pm | Discussion |
7:25 pm - 7:50 pm | Patrick Schloss (Central Institute of Mental Health, Mannheim, Heidelberg University, Germany) "Serotonin – More than a Neurotransmitter – TGase-Mediated Serotonylation in Blood and Brain" |
7:50 pm - 8:00 pm | Discussion |
8:00 pm | Dinner |
Wednesday |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | What Role Do Transglutaminases Play in Neurological Disease? |
| Discussion Leader: Anne-Marie Van Dam (VU University Medical Center, The Netherlands) |
9:00 am - 9:20 am | Introduction by Discussion Leader |
9:20 am - 9:45 am | Scott Brady (University of Illinois at Chicago, USA) "Transglutaminase and Neuronal Functioning" |
9:45 am - 9:55 am | Discussion |
9:55 am - 10:20 am | M. Maral Mouradian (Robert Wood Johnson Medical School, Rutgers University, USA) "Transglutaminase 2 in Parkinson's Disease" |
10:20 am - 10:30 am | Discussion |
10:30 am - 11:00 am | Coffee Break |
11:00 am - 11:15 am | Micha Wilhelmus (VU University Medical Center, The Netherlands) "Transglutaminase 2 in Alzheimer's Diseasse" |
11:15 am - 11:20 am | Discussion |
11:20 am - 11:45 am | Daniel Aeschlimann (Cardiff University, United Kingdom) "Transglutaminase 6 in Relation to Neurological Dysfunction" |
11:45 am - 11:55 am | Discussion |
11:55 am - 12:05 pm | Selected from Poster Abstracts: Navina Chrobok (VU University Medical Center Amsterdam, The Netherlands) "Can Effects of Tissue Transglutaminase Inhibition on the Outcome of a Mouse Model for Multiple Sclerosis Be Attributed to Extracellular TG2?" |
12:05 pm - 12:10 pm | Discussion |
12:10 pm - 12:25 pm | Selected from Poster Abstracts: Christian Recktenwald (University of Gothenburg, Sweden) "Tissue Transglutaminase but Not Epidermal Transglutaminase Is Required for the Formation of a Bacteria-Impenetrable Mucus Layer" |
12:25 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:30 pm | Free Time |
4:30 pm - 6:00 pm | Poster Session |
6:00 pm - 8:00 pm | Celiac Disease, Gastroenterology and Transglutaminases |
| Discussion Leader: Katri Lindfors (University of Tampere, Finland) |
6:00 pm - 6:20 pm | Introduction by Discussion Leader |
6:20 pm - 6:45 pm | Ludvig Sollid (University of Oslo, Norway) "TG2 Autoantibody Response in Celiac Disease" |
6:45 pm - 6:55 pm | Discussion |
6:55 pm - 7:15 pm | Aaron Lerner (Technion - Israel Institute of Technology, Israel / Aesku.Kipp Institute, Germany) "Microbial Transglutaminase Is a New Bio-Marker and a Potential Inducer of Celiac Disease" |
7:15 pm - 7:25 pm | Discussion |
7:25 pm - 7:50 pm | Renato Monteiro (Center for Research on Inflammation, Université Paris Diderot, France) "Transglutaminase
2 and Gluten: Essential Pivots in the Pathogenesis of IgA Nephropathy" |
7:50 pm - 8:00 pm | Discussion |
8:00 pm | Dinner |
Thursday |
7:30 am - 8:30 am | Breakfast |
8:30 am - 9:00 am | Business Meeting |
| Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair |
9:00 am - 12:30 pm | Transglutaminases in Oncology |
| Discussion Leader: Daniela Matei (Northwestern University, USA) |
9:00 am - 9:20 am | Introduction by Discussion Leader |
9:20 am - 9:45 am | Richard Eckert (University of Maryland School of Medicine, USA) "Transglutaminases in Skin Cancer Stem Cells" |
9:45 am - 9:55 am | Discussion |
9:55 am - 10:20 am | Wenguo Jiang (Cardiff University School of Medicine, United Kingdom) "TG4 and Prostate Cancer" |
10:20 am - 10:30 am | Discussion |
10:30 am - 11:00 am | Coffee Break |
11:00 am - 11:15 am | Salvatore Condello (Northwestern University, USA) "TG2-FN-Integrin Complex in Ovarian Cancer Stem Cells" |
11:15 am - 11:20 am | Discussion |
11:20 am - 11:45 am | Federica Rossin (University of Rome Tor Vergata, Italy) "How Does TG2 Participate in Bioenergetic Metabolism" |
11:45 am - 11:55 am | Discussion |
11:55 am - 12:05 pm | Selected from Poster Abstracts: Uwe Ackermann (Austin Health, Australia) "Imaging of TG2 Activity in Breast Cancer Using Radiolabelled Hitomi Peptides" |
12:05 pm - 12:10 pm | Discussion |
12:10 pm - 12:25 pm | Selected from Poster Abstracts: Magdalena Adamczyk (Cardiff University, United Kingdom) "The Emerging Role of TG2 During Early Osteoarthritis" |
12:25 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:30 pm | Free Time |
4:30 pm - 6:00 pm | Poster Session |
6:00 pm - 8:00 pm | The Contribution of Transglutaminases to Connective Tissue Disorders |
| Discussion Leader: Mari Kaartinen (McGill University, Canada) |
6:00 pm - 6:20 pm | Introduction by Discussion Leader |
6:20 pm - 6:45 pm | Matthew Flick (Cincinnati Children's Hospital Medical Center, USA) "FXIII-A and Arthritis and Bone Erosion" |
6:45 pm - 6:55 pm | Discussion |
6:55 pm - 7:15 pm | Huifang Sun (Faculty of Dentistry, McGill University, Canada) "Transglutaminases, Bone Resorption and Osteoclastogenesis" |
7:15 pm - 7:25 pm | Discussion |
7:25 pm - 7:50 pm | Martine Charbonneau (Université de Sherbrooke, Canada) "TG2, Invadopodia and Cartilage Breakdown" |
7:50 pm - 7:55 pm | Discussion |
7:55 pm - 8:00 pm | Closing Remarks |
8:00 pm | Dinner |
Friday |
7:30 am - 8:30 am | Breakfast |
9:00 am | Departure |